Arrhythmia Research Technology (HRT) Widens Q2 Loss to 37c/Share

Arrhythmia Research Technology (AMEX: HRT) reported Q2 EPS of ($0.37), versus ($0.09) reported last year. Revenue for the quarter came in at $4.98 million, versus $6.02 million reported last year.

For earnings history and earnings-related data on Arrhythmia Research Technology (HRT) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
• Hitachi Ltd. (HIT) Misses Q2 EPS by 7c